Expression of p270 (ARID1A), a component of human SWI/SNF complexes, in human tumors

International Journal of Cancer

Volumn 112, Issue 4, 2004, Pages 636-642

  Wang, Xiaomei ^a   Nagl Jr , Norman G ^a   Flowers, Stephen ^a   Zweitzig, Daniel ^a   Dallas, Peter B ^a,b   Moran, Elizabeth ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Breast cancer; Kidney cancer; p270; SWI SNF; Tumor suppression

Indexed keywords

PROTEIN; PROTEIN P270; UNCLASSIFIED DRUG;

ARTICLE; CANCER SCREENING; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR; TUMOR CELL LINE;

BREAST NEOPLASMS; CARCINOMA, RENAL CELL; CELL DIVISION; CHROMOSOMAL PROTEINS, NON-HISTONE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOBLOTTING; KIDNEY NEOPLASMS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 7044247653     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20450     Document Type: Article

References (31)

1. Klochendler-Yeivin A, Yaniv M. Chromatin modifiers and tumor suppression. Biochim Biophys Acta 2001;1551:M1-10.
2. Muchardt C, Yaniv M. When the SWI/SNF complex remodels ... the cell cycle. Oncogene 2001;20:3067-75.
3. Kadonaga JT. Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 1998;92:307-13.
4. Kingston RE, Narlikar GJ. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev 1999;13:2339-52.
5. Peterson CL, Workman JL. Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr Opin Genet Dev 2000;10:187-92.
6. Tsukiyama T. The in vivo functions of ATP-dependent chromatin-remodelling factors. Nat Rev Mol Cell Biol 2002;3:422-9.
7. Vignali M, Hassan AH, Neely KE, Workman JL. ATP-dependent chromatin-remodeling complexes. Mol Cell Biol 2000;20:1899-910.
8. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 1993;366:170-4.
9. Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, Ghaffari S, Iliev D, Penn B, Woodland AM, Smith R, Salada G, et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 2000;60:6171-7.
10. DeCristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Physiol 2001;186:136-45.
11. Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, Randazzo F, Metzger D, Chambon, P, Crabtree G, Magnuson T. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 2000;6:1287-95.
12. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998;394:203-6.
13. DeCristofaro MF, Betz BL, Wang W, Weissman BE. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors. Oncogene 1999;18:7559-65.
14. Uno K, Takita J, Yokomori K, Tanaka Y, Ohta S, Shimada H, Gilles FH, Sugita K, Abe S, Sako M, Hashizume K, Hayashi Y. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Genes Chromosomes Cancer 2002;34:33-41.
15. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002;8:3461-7.
16. Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep 2000;1:500-6.
17. Guidi CJ, Sands AT, Zambrowicz BP, Turner TK, Demers DA, Webster W, Smith TW, Imbalzano, AN, Jones SN. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol 2001;21:3598-603.
18. Kim JK, Huh SO, Choi H, Lee KS, Shin D, Lee C, Nam JS, Kim H, Chung H, Lee HW, Park SD, Seong RH. Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development. Mol Cell Biol 2001;21:7787-95.
19. Dallas PB, Cheney IW, Liao D, Bowrin V, Byam W, Pacchione S, Kobayashi R, Yaciuk P, Moran E. p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes. Mol Cell Biol 1998;18:3596-603.
20. Dallas PB, Pacchione S, Wilsker D, Bowrin V, Kobayashi R, Moran E. The human SWI/SNF complex protein, p270, is an ARID family member with nonsequence-specific DNA binding activity. Mol Cell Biol 2000;20:3137-46.
21. Nie Z, Xue Y, Yang D, Zhou S, Deroo BJ, Archer TK, Wang W. A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol 2000;20:8879-88.
22. Wilsker D, Patsialou A, Dallas PB, Moran E. ARID proteins: a new family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ 2002;13:95-106.
23. Beck GR Jr, Sullivan EC, Moran E, Zerler B. Relationship between alkaline phosphatase levels, osteopontin expression and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem 1998;68:269-80.
24. Reisman, DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser W Jr, Murchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs. CD44 expression. Oncogene 2002;21:1196-207.
25. van Bokhoven A, Varella-Garcia M, Korch C, Miller GJ. TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res 2001;61:6340-4.
26. Fogh J, Trempe G: New human tumor cell lines; in Fogh J (ed): Human Tumor Cells in vitro. New York, Plenum Press, 1975, pp 115-59.
27. Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 2003;63:560-6.
28. Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J 1998;17:6979-91.
29. Kortschak RD, Tucker PW, Saint R. ARID proteins come in from the desert. Trends Biochem Sci 2000;25:294-9.
30. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986;321:209-13.
31. Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol 2003;4:351-8.